Skip to Main content Skip to Navigation
Journal articles

Predicting and Overcoming Taxane Chemoresistance

Abstract : Taxanes are microtubule-targeting drugs used as cytotoxic chemotherapy to treat most solid tumors. The development of resistance to taxanes is a major cause of therapeutic failure and overcoming chemoresistance remains an important challenge to improve patient's outcome. Extensive efforts have been made recently to identify predictive biomarkers to select populations of patients who will benefit from taxane-based chemotherapy and avoid inefficient treatment of patients with innate resistance. This, together with the discovery of new mechanisms of resistance that include metabolic reprogramming and dialogue between tumor and its microenvironment, pave the way to a new era of personalized medicine. In this review, we recapitulate recent insights into taxane resistance and present promising emerging strategies to overcome chemoresistance in the future.
Complete list of metadata
Contributor : Clara NAHMIAS Connect in order to contact the contributor
Submitted on : Tuesday, November 24, 2020 - 2:43:38 PM
Last modification on : Monday, December 13, 2021 - 9:17:17 AM
Long-term archiving on: : Thursday, February 25, 2021 - 8:11:02 PM


 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document



Sylvie Rodrigues-Ferreira, Hadia Moindjie, Maria Haykal, Clara Nahmias. Predicting and Overcoming Taxane Chemoresistance. Trends in Molecular Medicine, Elsevier, 2020, S1471-4914 (20), pp.30238-0. ⟨10.1016/j.molmed.2020.09.007⟩. ⟨inserm-03014872⟩



Record views